Globe Life (NYSE:GL) Updates FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 14.950-15.650 for the period, compared to the consensus earnings per share estimate of 15.030. The company issued revenue guidance of -.

Globe Life Stock Up 0.8%

NYSE:GL traded up $1.14 on Wednesday, hitting $144.79. The stock had a trading volume of 797,458 shares, compared to its average volume of 530,000. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life has a 52 week low of $109.38 and a 52 week high of $147.83. The business’s fifty day moving average is $138.70 and its 200 day moving average is $137.68. The company has a market cap of $11.53 billion, a PE ratio of 10.49 and a beta of 0.47.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts expect that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Monday, January 5th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Monday, January 5th. This represents a $1.08 annualized dividend and a dividend yield of 0.7%. Globe Life’s payout ratio is presently 7.83%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on GL shares. Wells Fargo & Company cut their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Keefe, Bruyette & Woods raised their price target on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Piper Sandler restated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. Finally, Evercore ISI downgraded shares of Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective for the company. in a report on Tuesday, January 6th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.22.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 9,379 shares of the stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.97% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Globe Life

Large investors have recently bought and sold shares of the stock. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life in the 2nd quarter worth approximately $28,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life during the second quarter valued at approximately $31,000. Banque Cantonale Vaudoise purchased a new stake in Globe Life in the third quarter worth $50,000. Advisory Services Network LLC bought a new position in Globe Life in the third quarter worth $72,000. Finally, Headlands Technologies LLC lifted its position in Globe Life by 893.6% during the second quarter. Headlands Technologies LLC now owns 775 shares of the company’s stock valued at $96,000 after buying an additional 697 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.